0.5

Sep 11, 2014

10 likes | 144 Views

A. 3.5. 3. 2.5. 2. Normalized Mean Expression Values. 1.5. 1. 0.5. 0. Donor 2. Donor 1. LXR a. LXR b. B. 60kDa. LXR .

Share Presentation

Embed Code

Link

yered

Download Presentation

0.5

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

A 3.5 3 2.5 2 Normalized Mean Expression Values 1.5 1 0.5 0 Donor 2 Donor 1 LXRa LXRb B 60kDa LXR

0.5

1. Fraction Viable. 0.5. rpl6b D (31.6). 0. 0. 20. 40. 60. 80. Age (generations). A. B. 1. Fraction Viable. 0.5. idh2 D (30.3). wt (25.9). wt (25.6). 0. 0. 20. 40. 60. Age (generations). C. D. 1. 1. Fraction Viable. Fraction Viable. 0.5. 0.5. tor1 D (30.6).

377 views • 4 slides

0.5

A Profiling Exercise of Childhood Immunisation Practices in Edinburgh Kennedy, C*., McIntosh, P^., Hogg, R^., Christie, J*. & Gray, C*.. *School of Nursing, Midwifery & Social Care, Napier University; ^ NHS Lothian. Background.

141 views • 2 slides

0.5

a. Atria. Ventricles. Ang II (hr):. 0.5. 2. 5. 24. 0. 0.5. 2. 5. 24. 0. ATF3. Tubulin. 1. 2. 3. 4. 5. 1. 2. 3. 4. 5. (hr):. (hr):. Atria. Ventricles. Figure S1: Kinetics of ATF3 expression in response to angiotensin II in atria versus ventricles. a.

160 views • 2 slides

§ 0.5

§ 0.5. Exponents and Power Functions. Section Outline. Exponent Rules Applications of Exponents Compound Interest. Exponents. Exponents. Exponents. Exponents. Exponents. Applications of Exponents. EXAMPLE. Use the laws of exponents to simplify the algebraic expression. SOLUTION.

398 views • 12 slides

0.5

2.5. 8.0. PCBs. 7.0. p.p ’ -DDE. 2.0. 6.0. 1.5. 5.0. 4.0. 1.0. 3.0. 2.0. 0.5. 1.0. 0. 0. 1.2. 0.6. Trans-nonachlor. 1.0. Q1. 0.5. 0.8. 0.4. 0.6. 0.3. 0.4. 0.2. (  g/g lipid). 0.2. 0.1. 0. 0. 0.12. 0.06. 0.10. HCB. TBA. 0.05. 0.08. 0.04. 0.06. 0.03. 0.04.

114 views • 1 slides

0.5

LAI Values. Lubrecht Exp. Forest Montana. 0.5. 1.9. 1.0.

149 views • 1 slides

0.5

6. A. 4. L-methionine uptake (nmol/mg dry weight). 2. 0. 2. B. 1.5. D-methionine uptake (nmol/mg dry weight). 1. 0.5. 0. 0. 2. 10. 4. 6. 8. Time (min). Figure S3. Inhibition of the uptake of 1-[ 14 C]L-methionine (A) and 1-[ 14 C]

153 views • 1 slides

0.5

20.33 N. Ross Wagenseil for CDMP January 2000. 71.25 W. 75 W. 1. DEGREES. MILES. KILOMETERS. 100. 0.5. 100. 50. 0. 10yr. 25yr. 50yr. 100yr. SELECT. 50. Wind. 25. CDMP. 17.5 N. Wave. Surge. 0. 0. Haiti Probable Storm Effects.

248 views • 13 slides

0.5

4. 3. Relative FOSL1 mRNA level. 2. 1. 0. 0. 0.5. 1. 1.5. Relative miR-138 level.

118 views • 1 slides

0.5

12. 35. 40. 30.4. 33.8. 32.8. 10. 30. 28.3. 30. 25. 8. 20. 6. Luciferase Fold Induction. 20. 13.0. Luciferase fold induction. Luciferase Fold Induction. 15. 4. 10. 10. 2. 3.1. 5. 1.8. 1.2. 1.0. 1.0. 0.9. 0. 0. 0. 0. 0.5. 1. 1.5. Elf-1. Fli-1. PU.1. PEA3.

157 views • 1 slides

0.5

A. A. 4. Reporter: coll-73-luc +NLSA. 3.5. 3. 2.5. Relative luciferase value. 2. 1.5. 1. 0.5. 0. NH. E2. DES. PPT. Estren. OHT. Ral. Idox. Nafox. ICI. E2+ICI. B. 3.5. Reporter: coll-73-luc + ER  148-530 Flag. 3. 2.5. Relative luciferase value. 2. 1.5. 1. 0.5.

155 views • 1 slides

0.5

Supplemental Figure 3. Ngn3. HES1. Hexokinase 2. 4. 2.5. 8. 2. 3. 6. 1.5. 4. 2. 1. 2. 1. 0.5. 0. 0. 0. Ngn3-EGFP +. Ngn3-EGFP -. Ngn3-EGFP +. Ngn3-EGFP -. Ngn3-EGFP +. Ngn3-EGFP -. Insulin I. Pdx-1. MafA. 15. 2. 3. 1.5. 10. 2. 1. 5. 1. 0.5. 0. 0. 0.

151 views • 1 slides

0.5

2.0. 1.5. OD 620 nm. *. H37Rv. 1.0. *. Mt D P27. *. *. Mt D P27::P27. Mt D P27::P55. *. *. 0.5. *. Mt D P27::P27-P55. *. *. *. 0. 15. 50. 45. 30. Time (min).

140 views • 1 slides

0.5

1.5. 30. ns. ns. 1.0. 20. mg/dl. mg/dl. 0.5. 10. 0. 0. PBS/EtOH. PBS/EtOH. Oxa. Oxa.

150 views • 1 slides

0.5

Effectiveness in Reducing Trait Anxiety Meta-analysis of 146 studies. TM. Placebo. Other Relaxation. Relaxation Response. Other Meditations. PMR. EMG-Biofeedback. Mantra Meditation. Concentration. 0. 0.5. 1. Effect Size (Standard Deviations)

261 views • 9 slides

0.5

m. 5. 4. 3. 2,3. 2. ?. 1. 0.5. 2.5. m. The graphs to the right illustrate a fountain shooting a jet of water with a laser beam illuminating the jet in two places, one of them being (2 m ,3 m). Determine the height of the other point illuminated by the laser.

218 views • 7 slides

0.5

19.5 N. Ross Wagenseil for CDMP January 2000. 68 W. 1. 64 W. DEGREES. MILES. KILOMETERS. 100. 0.5. 100. 50. 0. 10yr. 25yr. 50yr. 100yr. SELECT. 50. Wind. 25. CDMP. 17 N. Wave. Surge. 0. 0. Points of Interest: The mountains of Puerto Rico show

624 views • 52 slides

0.5

Low expression. High expression. 1.0. 3. 0.75. 11. 13. 1. 2. 6. 5. 9. 14. 12. 10. 7. 0.5. Sensitvity (TPF). 8. 4. NBC-Hst. 0.25. NBC-Sst. FL. CLL. 0. 0.25. 0.5. 0.75. 1.0. 1-Specificity (FPF). CLL. FL. High expression. 0. 7. P<0.001. Low expression. 2. 11.

112 views • 1 slides

0.5

0. 0.5. 1.

175 views • 1 slides

0.5

3.5. 3.0. 2.5. 2.0. [ cDNA xtrD ]/[ cDNA tubC ]. 1.5. 1.0. 0.5. 0. 0.2 %. 0.5 %. 1 %. 2 %. 0.2 %. 0.5 %. 1 %. 2 %. Xylose. Glucose. Additional file 4 – The qPCR for xtrD upon A. nidulans growth on different concentrations of glucose or xylose.

142 views • 1 slides

0.5

A. 2.5. 2. 1.5. 1. 0.5. 0. 0. 500. 1000. 1500. 2000. 2500. 3000. 3500. size of Intron 2 in orthologouse MYB10 gene. Intron 2 (from 82 bp to 3000 bp). Intron 1. Exon 2. Exon 1. Exon 3. 100~130. 83~ 371. 130. 264~2981. 415~517. B. C. Additional file 1

111 views • 1 slides

More Related